Peter Barth

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger et al. · Journal of Clinical Oncology · 2009 · 2.5K citations

Octreotide Versus Octreotide Plus Interferon-Alpha in Endocrine Gastroenteropancreatic Tumors: A Randomized Trial

Rudolf Arnold, Anja Rinke, Klaus‐Jochen Klose et al. · Clinical Gastroenterology and Hepatology · 2005 · 252 citations · Full text

Endocrine Oncology, Surgical Oncology, Gastrointestinal Oncology +10

Nonviral siRNA Delivery to the Lung: Investigation of PEG−PEI Polyplexes and Their In Vivo Performance

Olivia M. Merkel, Andrea Beyerle, Damiano Librizzi et al. · Molecular Pharmaceutics · 2009 · 187 citations

CDKN2A Germline Mutations in Familial Pancreatic Cancer

Detlef K. Bartsch, Mercedes Sina‐Frey, Sven Arke Lang et al. · Annals of Surgery · 2002 · 183 citations · Full text

Localization of Osteoprotegerin, Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand, and Receptor Activator of Nuclear Factor-κB Ligand in Monckeberg’s Sclerosis and Atherosclerosis

Michael Schoppet, Nadia Al‐Fakhri, Folker E. Franke et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 181 citations